Author

César Augusto Barros Duarte

ORCID 0009-0004-8864-3357Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:variant calling· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Sueli Massumi Nakatani· 2 shared André E. Varaschin· 1 shared C. A. M. dos SantosiD· 1 shared Cléverton SpautziD· 1 shared Cristine Domingues D. de Oliveira· 1 shared Kamilla Leitão· 1 shared Laura Masami Sumita· 1 shared Sílvia Regina HokazonoiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Sueli Massumi Nakatani

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintAug 19, 2025

Urinary microRNA Profiles Discriminate Bladder Cancer from Healthy Individuals: A Pilot Study Using qPCRAcross Urine Fractions.

César Augusto Barros Duarte, Kamilla Leitão, Sílvia Regina Hokazono…·Sueli Massumi Nakatani

This study uses qPCR to analyze urinary microRNA profiles in bladder cancer patients and healthy controls, finding that combined miRNA expression can distinguish between the two groups.

DOI 10.1101/2025.08.19.25333993

humanbulk RNA-seq

𝕏 PostBluesky

Genetic & Genomic MedicinemedRxivPreprintFeb 8, 2024

Hereditary breast cancer next-generation sequencing (NGS) panel evaluation in the south region of Brazil: a novel BRCA2 candidate pathogenic variant is reported.

César Augusto Barros Duarte, C. A. M. dos Santos, Cristine Domingues D. de Oliveira…·Sueli Massumi Nakatani

The paper evaluates a next-generation sequencing panel for hereditary breast cancer in a Brazilian population, identifying two pathogenic variants and one novel candidate pathogenic variant in BRCA2.

1 citation

humanwhole-exome sequencing

𝕏 PostBluesky